Articles in Scholarly Journals [Incomplete List]

1. Does a delay in initiating definitive therapy affect biochemical recurrence rates in men with clinically localized prostate cancer?
   Urologic Oncology: Seminars and Original Investigations, vol. 25, no. 3, pp. 196–200, 2007
2. Editorial Comment
   The Journal of Urology, 2007
3. A Simple Model Predicts Freedom From Biochemical Recurrence After Low-Dose Rate Prostate Brachytherapy Alone
   American Journal of Clinical Oncology, vol. 30, no. 2, pp. 199–204, 2007
4. Microwave Ablation of Renal Parenchymal Tumors Before Nephrectomy: Phase I Study
   American Journal of Roentgenology, vol. 188, no. 5, pp. 1212–1214, 2007
5. Bladder cancer
   Current Opinion in Oncology, vol. 18, no. 3, p. 277???283, 2006
6. Pretreatment PSA velocity is associated with freedom from biochemical recurrence of prostate cancer following low-dose-rate prostate brachytherapy alone
   Brachytherapy, vol. 5, no. 2, pp. 79–79, 2006
7. DNA damage levels in prostate cancer cases and controls
   Carcinogenesis, vol. 27, no. 6, pp. 1187–1193, 2006
8. Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy
   Urology, vol. 67, no. 6, pp. 1257–1261, 2006
9. Complementary and Alternative Medicine for Advanced Prostate Cancer
   Urologic Clinics of North America, vol. 33, no. 2, pp. 237–246, 2006
10. Vinorelbine, doxorubicin, and prednisone in androgen-independent prostate cancer
    Cancer, vol. 107, no. 5, pp. 1093–1100, 2006
11. Percentage of positive biopsies associated with freedom from biochemical recurrence after low-dose-rate prostate brachytherapy alone for clinically localized prostate cancer
    Urology, vol. 67, no. 2, pp. 349–353, 2006
12. Contemporary Management of the Urethra in Patients After Radical Cystectomy for Bladder Cancer
    Urologic Clinics of North America, vol. 32, no. 2, pp. 199–206, 2005
13. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era
    Urologic Oncology: Seminars and Original Investigations, vol. 23, no. 5, pp. 328–332, 2005
14. Inflammatory myofibroblastic tumor associated with renal cell carcinoma
    Urology, vol. 66, no. 4, pp. 880.e7–880.e9, 2005
15. Radical cystectomy in the elderly
    Cancer, vol. 103, no. 3, pp. 546–552, 2005
16. Bladder cancer
    Current Opinion in Oncology, vol. 17, no. 3, pp. 275–280, 2005
17. Dosimetric quantifiers for low-dose-rate prostate brachytherapy: Is V100 superior to D90?
    Brachytherapy, vol. 4, no. 4, pp. 252–258, 2005
18. Radical cystectomy in the elderly
    Cancer, vol. 104, no. 1, pp. 36–43, 2005
19. Recent advances in the treatment of bladder cancer
    Expert Review of Anticancer Therapy, vol. 5, no. 6, pp. 1023–1030, 2005
20. The ADPRT V762A Genetic Variant Contributes to Prostate Cancer Susceptibility and Deficient Enzyme Function
    Cancer Research, vol. 64, no. 17, pp. 6344–6348, 2004
21. THE MANAGEMENT OF URETHRAL TRANSITIONAL CELL CARCINOMA AFTER RADICAL CYSTECTOMY FOR INVASIVE BLADDER CANCER
    The Journal of Urology, vol. 172, no. 4, pp. 1342–1347, 2004
22. Microscopic and Gross Extravesical Extension in Pathological Staging of Bladder Cancer
    The Journal of Urology, vol. 171, no. 2, pp. 640–645, 2004
23. Utility of frozen section analysis of resection margins during partial nephrectomy
    Urology, vol. 64, no. 1, pp. 31–34, 2004
24. Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma
    Urology, vol. 63, no. 6, pp. 1061–1065, 2004
25. Bladder cancer
    Current Opinion in Oncology, vol. 16, no. 3, pp. 257–262, 2004
26. Current Opinion in Oncology, vol. 15, no. 3, pp. 227–233, 2003
27. Natural history of surgically treated bladder carcinoma with extravesical tumor extension
    Cancer, vol. 98, no. 5, pp. 955–961, 2003
28. Prostate Cancer and Bone Metastases: Medical Treatment
    Clinical Orthopaedics and Related Research, vol. 415, pp. S148–S157, 2003
29. Angiomyolipoma with vena caval extension
    Urology, vol. 60, no. 4, pp. 695–696, 2002
30. Quality of life and psychological adaptation after surgical treatment for localized renal cell carcinoma: impact of the amount of remaining renal tissue
    Urology, vol. 57, no. 2, pp. 252–256, 2001
31. Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer
    Urology, vol. 57, no. 2, pp. 281–285, 2001
32. EXOPHYTIC NONINVASIVE GROWTH PATTERN OF RENAL ANGIOMYOLIPOMAS: : IMPLICATIONS FOR NEPHRON SPARING SURGERY
    The Journal of Urology, vol. 165, no. 2, pp. 513–514, 2001
33. Intermediate-Term Outcome with Radical Prostatectomy for Localized Prostate Cancer: The Cleveland Clinic Experience
    The Prostate Journal, vol. 3, no. 2, pp. 118–125, 2001
34. 13-YEAR EXPERIENCE WITH PERCUTANEOUS MANAGEMENT OF UPPER TRACT TRANSITIONAL CELL CARCINOMA
    The Journal of Urology, vol. 161, no. 3, pp. 772–776, 1999
35. Surgery for invasive bladder tumors: technique and outcome
    Current Opinion in Urology, vol. 9, no. 5, pp. 413–418, 1999
36. Alterations in NFkappaB Activation in T Lymphocytes of Patients With Renal Cell Carcinoma
    Journal of the National Cancer Institute, vol. 91, no. 8, pp. 718–721, 1999
37. Original Articles: Testis Cancer: A Review of Scrotal Violation in Testicular Cancer: Is Adjuvant Local Therapy Necessary?
    The Journal of Urology, vol. 153, no. 3, pp. 981–985, 1995